Extract inhibited expansion of the erythro leukemic mobile line K-562 by inducing apoptosis and mobile cycle arrest at G2/M phase. Anecdotal evidence from the clinical study [forty five] confirmed that oral administration of Rhodiola rosea While research remains preliminary, Rhodiola Rosea shows therapeutic opportunity as a result of its anticarcinogenic https://rhodiola-rosea-health-ben49257.ambien-blog.com/32845553/fascination-about-rhodiola-rosea-health-benefits